BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11781647)

  • 1. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.
    Porrata LF; Ingle JN; Litzow MR; Geyer S; Markovic SN
    Bone Marrow Transplant; 2001 Nov; 28(9):865-71. PubMed ID: 11781647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study.
    Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Gastineau DA; Litzow MR; Winters JL; Markovic SN
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):807-16. PubMed ID: 18541201
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Orrantia A; Vázquez-De Luis E; Astarloa-Pando G; Terrén I; Amarilla-Irusta A; Polanco-Alonso D; González C; Uranga A; Carrascosa T; Mateos-Mazón JJ; García-Ruiz JC; Callejas S; Quintas A; Dopazo A; Zenarruzabeitia O; Borrego F
    iScience; 2022 Oct; 25(10):105235. PubMed ID: 36262311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Trial of Neutrophil/Lymphocyte Ratio and Other Blood Counts as Biomarkers of Survival among Patients with High-Grade Soft Tissue Sarcomas Treated with Pegylated Liposomal Doxorubicin and Ifosfamide.
    Skubitz KM; Domingo-Musibay E; Lindgren BR; Cheng EY
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Infused Autograft Absolute Numbers of Immune Effector Cells on Survival Post-Autologous Stem Cell Transplantation.
    Porrata LF
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Adaptive Natural Killer Cell Expansion Is Associated with Decreased Relapse After Autologous Transplantation for Multiple Myeloma.
    Merino AM; Mehta RS; Luo X; Kim H; De For T; Janakiram M; Cooley S; Wangen R; Cichocki F; Weisdorf DJ; Miller JS; Bachanova V
    Transplant Cell Ther; 2021 Apr; 27(4):310.e1-310.e6. PubMed ID: 33836870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human NK Cells in Autologous Hematopoietic Stem Cell Transplantation for Cancer Treatment.
    Orrantia A; Terrén I; Astarloa-Pando G; Zenarruzabeitia O; Borrego F
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure.
    Gile JJ; Lopez CL; Ruan GJ; Hathcock MA; Abeykoon JP; Heimgartner JR; Baumann NA; McMahon MM; Micallef IN; Johnston PB; Bisneto JCV; Porrata LF; Paludo J; Ansell SM; Hogan WJ; Witzig TE
    Blood Cancer J; 2021 Mar; 11(3):65. PubMed ID: 33771971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infusion of autograft natural killer cell/CD14
    Kansagra A; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Hogan WJ; Markovic SN; Porrata LF
    Bone Marrow Transplant; 2018 Feb; 53(2):146-154. PubMed ID: 29035394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation.
    Tormo A; Khodayarian F; Cui Y; Al-Chami E; Kanjarawi R; Noé B; Wang H; Rafei M
    J Hematol Oncol; 2017 Jun; 10(1):120. PubMed ID: 28615039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients.
    Saeed L; Patnaik MM; Begna KH; Al-Kali A; Litzow MR; Hanson CA; Ketterling RP; Porrata LF; Pardanani A; Gangat N; Tefferi A
    Blood Cancer J; 2017 Mar; 7(3):e550. PubMed ID: 28362440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.
    Farkas T; Müller J; Erdelyi DJ; Csoka M; Kovacs GT
    Pathol Oncol Res; 2017 Oct; 23(4):889-897. PubMed ID: 28138921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous Graft-versus-Tumor Effect: Reality or Fiction?
    Porrata LF
    Adv Hematol; 2016; 2016():5385972. PubMed ID: 27635143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous detection of circulating immunological parameters and tumor biomarkers in early stage breast cancer patients during adjuvant chemotherapy.
    Rovati B; Mariucci S; Delfanti S; Grasso D; Tinelli C; Torre C; De Amici M; Pedrazzoli P
    Cell Oncol (Dordr); 2016 Jun; 39(3):211-28. PubMed ID: 26769126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK Cell Subgroups, Phenotype, and Functions After Autologous Stem Cell Transplantation.
    Jacobs B; Tognarelli S; Poller K; Bader P; Mackensen A; Ullrich E
    Front Immunol; 2015; 6():583. PubMed ID: 26635797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma.
    Rochet NM; Kottschade LA; Grotz TE; Porrata LF; Markovic SN
    Am J Clin Oncol; 2015 Jun; 38(3):252-8. PubMed ID: 23774073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy with autologous stem cell transplant for breast cancer: what have we learned 25 years later?
    Nieto Y; Shpall EJ
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):3-5. PubMed ID: 22146617
    [No Abstract]   [Full Text] [Related]  

  • 18. Autograft mediated adoptive immunotherapy of cancer in the context of autologous stem cell transplantation.
    Porrata LF; Markovic SN
    World J Clin Oncol; 2010 Nov; 1(1):29-34. PubMed ID: 21603308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-15 affects patient survival through natural killer cell recovery after autologous hematopoietic stem cell transplantation for non-Hodgkin lymphomas.
    Porrata LF; Inwards DJ; Micallef IN; Johnston PB; Ansell SM; Hogan WJ; Markovic SN
    Clin Dev Immunol; 2010; 2010():914945. PubMed ID: 20414345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy.
    Sportès C; Babb RR; Krumlauf MC; Hakim FT; Steinberg SM; Chow CK; Brown MR; Fleisher TA; Noel P; Maric I; Stetler-Stevenson M; Engel J; Buffet R; Morre M; Amato RJ; Pecora A; Mackall CL; Gress RE
    Clin Cancer Res; 2010 Jan; 16(2):727-35. PubMed ID: 20068111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.